Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000812

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Dec 16, 2022 78.36M sh
Operating Cash Flow Q3 2018 · Jun 30, 2019 −$1.71K
Operating Cash Flow Q3 2018 · Jun 30, 2018 −$28.63K
Current Liabilities Q3 2018 · Jun 30, 2019 $231.81K
Current Liabilities Q3 2018 · Sep 30, 2018 $223.36K
Total Liabilities Q3 2018 · Jun 30, 2019 $231.81K
Total Liabilities Q3 2018 · Sep 30, 2018 $223.36K
Current Assets Q3 2018 · Jun 30, 2019 $558
Current Assets Q3 2018 · Sep 30, 2018 $2.27K
Total Assets Q3 2018 · Jun 30, 2019 $558
Total Assets Q3 2018 · Sep 30, 2018 $2.27K
Net Income Q3 2018 · Jun 30, 2019 −$10.16K
Net Income Q3 2018 · Jun 30, 2018 −$4.28K
Net Income Q3 2018 · Jun 30, 2018 −$21.3K
Net Income Q3 2018 · Mar 31, 2018 −$9.39K
Net Income Q3 2018 · Dec 31, 2017 −$7.63K
Operating Income Q3 2018 · Jun 30, 2019 −$4.21K
Operating Income restated Q3 2018 · Jun 30, 2018 −$3K
Operating Income restated Q3 2018 · Jun 30, 2018 −$18.21K
Stockholders Equity Q3 2018 · Sep 30, 2018 −$221.09K
Stockholders Equity restated Q3 2018 · Jun 30, 2018 −$213.99K
Stockholders Equity Q3 2018 · Mar 31, 2018 −$209.7K
Stockholders Equity Q3 2018 · Dec 31, 2017 −$200.31K
Stockholders Equity Q3 2018 · Sep 30, 2017 −$192.69K